Kiel

Kiel Laboratories is a pharmaceutical research and development company specializing in the development of intellectual property and technology for 505(b)(2) and orphan drug submissions. Founded in 1991 and based in Georgia, the company provides end-to-end solutions including formulation development, analytical services, and regulatory strategy. With 16 FDA-approved New Drug Applications (NDAs), Kiel acts as a strategic partner for pharmaceutical companies looking to accelerate their path to market through innovative drug delivery and lifecycle management. The company is employee-owned and maintains a strong focus on patient-centric solutions for geriatric, pediatric, and rare disease populations.